View Article

  • Solubility Enhancement, Formulation And Evaluation Of Dolutegravir

  • Department of Pharmaceutical Quality Assurance, Mahatma Gandhi Vidyamandir's Pharmacy College, Nashik

Abstract

Dolutegravir is an HIV-1 antiviral agent used to control HIV/AIDS. In the present study, Dolutegravir inclusion complexes have been subjected to improvement in solubility and dissolution rate performance by being formulated as immediate release tablets, in which ?- CD were used as polymers. Inclusion complexes of dolutegravir were prepared with different ratios of dolutegravir and ?-CD (1:0.5, 1:1, and 1:2) by the kneading method. The pre-compression and post-evaluation parameters were studied, and the results were shown. All the results were within acceptable IP limits. Finally, by comparing all the dissolution profiles of the inclusion complex, Formulation F2 containing Dolutegravir + ?- CD (1:2) showed better results by the kneading method at the end of 45 min with maximum drug release; hence, it is selected as the best formulation. From the obtained optimized inclusion complex formulation, the Immediate release tablets were prepared by using different concentrations of various solubility enhancers and super disintegrants. The in-vitro drug releases of the formulated Dolutegravir tablets were performed using a 6.8 pH Phosphate buffer as a dissolution medium. The optimized F2 formulation contained Sodium starch glycolate (SSG) (6% w/w) as a super disintegrant, and it showed 99.75% drug release at 45 min. Characterization in the solid-state was done by analytical methods such as UV-visible and FT-IR studies.

Keywords

Solubility enhancement, Complexation, Tablet

Reference

  1. Leunar C, Dreessan J. Improving drug solubility for oral delivery using solid dispersion. Eur J Pharm Biopharm 2000; 50:47-60.
  2. Aulton’s Pharmaceutics, The design and manufacture of medicines Biopharmaceutics and Pharmacokinetics. A treatise, Second edition, Vallabhs prakashan, 315-384.
  3. PS Argade, DD Magar, RB Saudagar. Review article on solid dispersion as solubility enhancement technique for poorly water soluble drugs. J Adv Pharm Edu Res 2013; 3:427-39.
  4. Liu L, Zhu S. Preparation and characterization of inclusion complexes of prazosin hydrochloride with ?-cyclodextrin and hydroxypropyl-?-cyclodextrin. Journal of pharmaceutical and biomedical analysis. 2006 Jan 23;40(1):122-7. Rajendra. B. Patil et al /J. Pharm. Sci. & Res. Vol. 11(9), 2019, 3102-3107
  5. Loh GO, Tan YT, Peh KK. Enhancement of norfloxacin solubility via inclusion complexation with ?-cyclodextrin and its derivative hydroxypropyl-?-cyclodextrin. asian journal of pharmaceutical sciences. 2016 Aug 1;11(4):536-46.
  6. Ghosh A, Biswas S, Ghosh T. Preparation and evaluation of silymarin ?-cyclodextrin molecular inclusion complexes. Journal of Young Pharmacists. 2011 Jul 1;3(3):205-10.
  7. Rajput N, Thakare VM, Tejade BW, Chaudari KP, Jadhao UT. Formulation and evaluation of fast dissolving tablet by inclusion complexation. Asian J Pharm Sci Technol, 2014; 4: 15-20.
  8. Azharuddin M, Kamath K, Shabaraya AR. Design and evaluation of fast dissolving tablets of carvedilol using sublimation technique. Indian J Pharm Sci. Res., 2012; 3: 3788-94.
  9. Rao PM, Babu AM, Sree KN, Rameswarapu NS, Mallikharjunarao KL, Prasanna kumar Desu. Formulaion Development and in-vitro evaluation of Immediate release tablets of biperiden Hcl cyclodextrin complexes. Int J Res Pharm Nano sci, 2013; 2: 757-67.
  10. Giri TK, Biswanath SA. Preparation and evaluation of rapidly disintegrating Fast release tablet of Diazepam-Hydroxypropyl-?-Cyclo dextrin inclusion Complex. Sci Res Pharmacol Pharm 2010; 1: 18-26.
  11. Bhanja SB, Ellaiah P, Nayak BS, Mahapatra DK, Sahu A, Padhy SK, et al. Enhancement of dissolution properties, preparation and evaluation of immediate release tablets of poorly soluble drug-repaglinide. Int J Pharm Technol, 2011; 3: 2961-91.
  12. Ratna JV, Sywalini V, Akshara T, Subbiah UV, Devi GS. Effect of hydrophilic polymers on solid dispersions of carvedilol for enhancing its dissolution rate. J Glob Trends Pharm Sci. 2012; 3: 708-13.
  13. Loyd V Allen. Remington-The Science & Practice of Pharmacy.22 nd Edition. The Pharmaceutical press, 2012; 687-690, 1313.
  14. Aulton ME, Taylor KM. Aultons Pharmaceutics. The Design and Manufacturing Medicines. Third Edition. Elsevier publication, 2007. p. 329, 335, 353.
  15. Chowdary KP, Devi GS. Effect of PVP on cyclodextrin complexation of efavirenz for enhancing its solubility and dissolution rate. Int J Res Pharm Chem 2012;2:311-6.
  16. Kumar O, Rani AP. Effect of polyvinylpyrrolidone on complexation and dissolution rate of beta cyclodextrin and hydroxypropyl beta cyclodextrin complexes of piroxicam. Int J Pharm Phytopharmacol Res 2012;1:301-30
  17. Rakesh Singh, Jain DA. Research Article Development, Characterization & Stabilization of Poorly Water Soluble Drugs Utilizing Solid Dispersion Techniques By Using ?-Cyclodextrin. J Drug Deliv Ther. 2013; 3(2): 74–79p.
  18. Indop MA, Sunita C Bhosle, Tayade PT and Vavia PR. Ind J of Pharm Sci. 2002;64(4):349-343.
  19. Dua K, Pabreja K, Ramana MV, Lather V. Dissolution behavior of ?-cyclodextrin molecular inclusion complexes of aceclofenac. J Pharm Bioallied Sci. 2011 Jul;3(3):417-25. doi: 10.4103/0975-7406.84457, PMID 21966164
  20. Al-Zein H, Sakeer K, Alanazi FK. Designing an extended release waxy matrix tablet containing nicardipine–hydroxy propyl ? cyclodextrin complex. Saudi Pharm J. 2011 Oct 1;19(4):245-53. doi: 10.1016/j.jsps.2011.05.004, PMID 23960765
  21. Jose Vicence Fernande- Montero, Pablo Barrerio, Pablo Labarg; Dolutegravir, abacavir and lamivudine as HIV therapy, 15(7), 2014, 1051-1057.

Photo
Renuka Sagane
Corresponding author

Department of Pharmaceutical Quality Assurance, Mahatma Gandhi Vidyamandir's Pharmacy College, Nashik

Photo
Kiran B. Erande
Co-author

Department of Pharmaceutical Quality Assurance, Mahatma Gandhi Vidyamandir's Pharmacy College, Nashik

Renuka Sagane, Kiran B. Erande, Solubility Enhancement, Formulation and Evaluation of Dolutegravir, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 1, 206-213. https://doi.org/10.5281/zenodo.10443939

More related articles
Cost-Effectiveness Analysis of L-Asparaginase vers...
Dr. Manjula G., Dr. Ashwini Doddannavar, Omkar Shedbale, ...
Formulation And Evaluation Of Tea Powder From Fenu...
Avantika .R. Dongare , Pankaj Vyawhare, ...
Therapeutic Potential of Hemidesmus Indicus...
Dr. Parvathy Prasad, Ashna Shiju , ...
Pharmacogenomics & Personalized Medicine: Exploring the Impact of Genetic Variat...
Biswa Bhusan Padhi, Tushar Kanti Das, Jeeban Pradeep Agnihotry, Chandrakanta Das, Sai Swagatika Das,...
Allelopathic Effects of Guizotia Abyssinica On Seed Germination of Horse Gram...
Dr. S. Shamshad, M. Suseelamma, R. R. Venkata Raju, ...
Invitro Study of Anti-Inflammatory, Anti-Oxidant and Anti-Microbial Activities o...
Mounika Karinki , Umalatha Kanupuri, Shanmukh Karanam, Dr. V. Bhaskararaju, Dhabal kumar Sathapathy,...
Related Articles
The Role of Vitamin-D Receptor in Alzheimer’s Disease: A Molecular and Clinica...
Vrushali Murari, Arun Pachauri, Kailash Singh Bisht, Anupama Sinha, Lokesh Paranjape, Omkar Sutar, ...
Solubility Enchantment Of Poorly Soluble Drug...
Kale kajal Santosh , Shinde S. B., ...
Repurposing Antiviral Agents for The Treatment of Neurodegenerative Disease: A P...
Vanashri Patil, Vrushali Khandekar, Satish Kurane, Sonam Pashte, Satyajeet Patil, ...
Personalized Drug In Cancer Forestallment And Treatment As Well As Its Unborn Di...
Prasanth Yerramsetti, Priyanka Gummadi, Abhishek Dey, ...
Cost-Effectiveness Analysis of L-Asparaginase versus PEG-Asparaginase in the Tre...
Dr. Manjula G., Dr. Ashwini Doddannavar, Omkar Shedbale, ...